NovoCure Limited

NovoCure Limitedverified

NVCR

Price:

$17.73

Market Cap:

$1.92B

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, ...[Read more]

Industry

Medical - Instruments & Supplies

IPO Date

2015-10-01

Stock Exchange

NASDAQ

Ticker

NVCR

The PE Ratio as of November 2024 (TTM) for NovoCure Limited (NVCR) is -12.76

According to NovoCure Limited’s latest financial reports and current stock price. The company's current PE Ratio is -12.76. This represents a change of 8.52% compared to the average of -11.76 of the last 4 quarters.

NovoCure Limited (NVCR) Historical PE Ratio (quarterly & annually)

How has NVCR PE Ratio performed in the past?

The mean historical PE Ratio of NovoCure Limited over the last ten years is -58.36. The current -12.76 PE Ratio has changed 2.09% with respect to the historical average. Over the past ten years (40 quarters), NVCR's PE Ratio was at its highest in in the September 2019 quarter at 953.98. The PE Ratio was at its lowest in in the June 2019 quarter at -1173.35.

Quarterly (TTM)
Annual

Average

-58.36

Median

-24.34

Minimum

-1133.36

Maximum

881.72

NovoCure Limited (NVCR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of NovoCure Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.24%

Maximum Annual PE Ratio = 881.72

Minimum Annual Increase = -177.80%

Minimum Annual PE Ratio = -1133.36

Quarterly (TTM)
Annual
YearPE RatioChange
2023-7.67-90.75%
2022-82.96-37.66%
2021-133.09-115.09%
2020881.72-177.80%
2019-1133.362.24%
2018-48.3766.75%
2017-29.01469.43%
2016-5.09-16.38%
2015-6.09-69.03%
2014-19.67-4.11%

NovoCure Limited (NVCR) Average PE Ratio

How has NVCR PE Ratio performed in the past?

The current PE Ratio of NovoCure Limited (NVCR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-74.57

5-year avg

-95.07

10-year avg

-58.36

NovoCure Limited (NVCR) PE Ratio vs. Peers

How is NVCR’s PE Ratio compared to its peers?

NovoCure Limited’s PE Ratio is less than Globus Medical, Inc. (0), less than Insulet Corporation (125.55), less than Inspire Medical Systems, Inc. (43.80), less than Inari Medical, Inc. (170.64), greater than TransMedics Group, Inc. (-36.88), less than InMode Ltd. (77.91), less than Integer Holdings Corporation (9.53), less than CONMED Corporation (40.94), less than LivaNova PLC (17.55), less than iRhythm Technologies, Inc. (117.78), greater than Heska Corporation (-15.35), greater than ShockWave Medical, Inc. (-67.36), less than Penumbra, Inc. (76.34), less than Masimo Corporation (273.64), less than null (117.51),

Build a custom stock screener for NovoCure Limited (NVCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovoCure Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NovoCure Limited (NVCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NovoCure Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is NovoCure Limited's PE Ratio?

How is the PE Ratio calculated for NovoCure Limited (NVCR)?

What is the highest PE Ratio for NovoCure Limited (NVCR)?

What is the 3-year average PE Ratio for NovoCure Limited (NVCR)?

What is the 5-year average PE Ratio for NovoCure Limited (NVCR)?

How does the current PE Ratio for NovoCure Limited (NVCR) compare to its historical average?